Prognostic significance of peroxiredoxin 1 and ezrin-radixin-moesin-binding phosphoprotein 50 in cholangiocarcinoma

Human Pathology

Volumn 43, Issue 10, 2012, Pages 1719-1730

  Yonglitthipagon, Ponlapat ^a,b   Pairojkul, Chawalit ^a   Chamgramol, Yaovalux ^a   Loukas, Alex ^b   Mulvenna, Jason ^b   Bethony, Jeffrey ^c   Bhudhisawasdi, Vajarabhongsa ^a   Sripa, Banchob ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

^b JAMES COOK UNIVERSITY   (Australia)

^c GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Cholangiocarcinoma; EBP50; Prognostic marker; Proteomics; PRX1; Tumor marker

Indexed keywords

BINDING PHOSPHOPROTEIN 50; BINDING PROTEIN; EZRIN; MOESIN; PEROXIREDOXIN 1; RADIXIN; UNCLASSIFIED DRUG;

ARTICLE; BILE DUCT CARCINOMA; BLOOD VESSEL; CANCER PROGNOSIS; CONTROLLED STUDY; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH VESSEL; PROTEIN EXPRESSION;

ADULT; AMINO ACID SEQUENCE; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CELL LINE, TUMOR; CHOLANGIOCARCINOMA; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PEROXIREDOXINS; PHOSPHOPROTEINS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTEOMICS; SODIUM-HYDROGEN ANTIPORTER; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84866489460     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2011.11.021     Document Type: Article

References (35)

1. B. Sripa, P. Sithithaworn, and S. Sirisinha Opisthorchis viverrini and opisthorchiasis: the 21st century review Acta Trop 88 2003 169 170 (Pubitemid 37377811)
2. B. Sripa, S. Kaewkes, and P. Sithithaworn Liver fluke induces cholangiocarcinoma PLoS Med 4 2007 e201
3. V. Bouvard, R. Baan, and K. Straif A review of human carcinogens B: biological agents Lancet Oncol 10 2009 321 322
4. P. Yonglitthipagon, C. Pairojkul, Y. Chamgramol, J. Mulvenna, and B. Sripa Up-regulation of annexin A2 in cholangiocarcinoma caused by Opisthorchis viverrini and its implication as a prognostic marker Int J Parasitol 40 2010 1203 1212
5. B. Sripa, S. Leungwattanawanit, and T. Nitta Establishment and characterization of an opisthorchiasis-associated cholangiocarcinoma cell line (KKU-100) World J Gastroenterol 11 2005 3392 3397 (Pubitemid 40873244)
6. H.L. Fedor, and A.M. De Marzo Practical methods for tissue microarray construction Methods Mol Med 103 2005 89 101
7. P.J. van Diest, P. van Dam, and S.C. Henzen-Logmans A scoring system for immunohistochemical staining: consensus report of the Task Force for Basic Research of the EORTC-GCCG. European Organization for Research and Treatment of Cancer-Gynaecological Cancer Cooperative Group J Clin Pathol 50 1997 801 804 (Pubitemid 27475783)
8. P.Y. Zhuang, J.B. Zhang, and X.D. Zhu Two pathologic types of hepatocellular carcinoma with lymph node metastasis with distinct prognosis on the basis of CK19 expression in tumor Cancer 112 2008 2740 2748
9. L. Zhong, X. Peng, G.E. Hidalgo, D.E. Doherty, A.J. Stromberg, and E.A. Hirschowitz Antibodies to HSP70 and HSP90 in serum in non-small cell lung cancer patients Cancer Detect Prev 27 2003 285 290 (Pubitemid 36990247)
10. C. Desmetz, F. Bibeau, and F. Boissiere Proteomics-based identification of HSP60 as a tumor-associated antigen in early stage breast cancer and ductal carcinoma in situ J Proteome Res 7 2008 3830 3837
11. Y.S. Chang, W. Wu, G. Walsh, W.K. Hong, and L. Mao Enolase-alpha is frequently down-regulated in non-small cell lung cancer and predicts aggressive biological behavior Clin Cancer Res 9 2003 3641 3644 (Pubitemid 37169229)
12. David CJ, Chen M, Assanah M, Canoll P, Manley JL. HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer. Nature 463:364-8.
13. J.H. Kim, P.N. Bogner, N. Ramnath, Y. Park, J. Yu, and Y.M. Park Elevated peroxiredoxin 1, but not NF-E2-related factor 2, is an independent prognostic factor for disease recurrence and reduced survival in stage I non-small cell lung cancer Clin Cancer Res 13 2007 3875 3882 (Pubitemid 47037594)
14. J. Song, J. Bai, W. Yang, E.W. Gabrielson, D.W. Chan, and Z. Zhang Expression and clinicopathological significance of oestrogen-responsive ezrin-radixin-moesin-binding phosphoprotein 50 in breast cancer Histopathology 51 2007 40 53 (Pubitemid 46976376)
15. M.M. Hay, T.R. Chen, P. McClintock, and Y. Reid American Type Culture Collection Catalogue of Cell Lines and Hybridomas 6th ed 1988 Md:ATCC Rockville
16. S.G. Rhee, S.W. Kang, T.S. Chang, W. Jeong, and K. Kim Peroxiredoxin, a novel family of peroxidases IUBMB Life 52 2001 35 41 (Pubitemid 33769667)
17. Y.J. Kim, W.S. Lee, C. Ip, H.Z. Chae, E.M. Park, and Y.M. Park Prx1 suppresses radiation-induced c-Jun NH2-terminal kinase signaling in lung cancer cells through interaction with the glutathione S-transferase Pi/c-Jun NH2-terminal kinase complex Cancer Res 66 2006 7136 7142 (Pubitemid 44197691)
18. M.K. Cha, K.H. Suh, and I.H. Kim Overexpression of peroxiredoxin I and thioredoxin1 in human breast carcinoma J Exp Clin Cancer Res 28 2009 93
19. T. Yanagawa, S. Iwasa, and T. Ishii Peroxiredoxin I expression in oral cancer: a potential new tumor marker Cancer Lett 156 2000 27 35 (Pubitemid 30326764)
20. J.W. Chang, H.B. Jeon, and J.H. Lee Augmented expression of peroxiredoxin I in lung cancer Biochem Biophys Res Commun 289 2001 507 512 (Pubitemid 33141083)
21. S. Pinlaor, Y. Hiraku, and N. Ma Mechanism of NO-mediated oxidative and nitrative DNA damage in hamsters infected with Opisthorchis viverrini: a model of inflammation-mediated carcinogenesis Nitric Oxide 11 2004 175 183 (Pubitemid 39371095)
22. X.Y. Wu, Z.X. Fu, and X.H. Wang Peroxiredoxins in colorectal neoplasms Histol Histopathol 25 2010 1297 1303
23. M.I. Berggren, B. Husbeck, B. Samulitis, A.F. Baker, A. Gallegos, and G. Powis Thioredoxin peroxidase-1 (peroxiredoxin-1) is increased in thioredoxin-1 transfected cells and results in enhanced protection against apoptosis caused by hydrogen peroxide but not by other agents including dexamethasone, etoposide, and doxorubicin Arch Biochem Biophys 392 2001 103 109 (Pubitemid 32725020)
24. S.Y. Kim, T.J. Kim, and K.Y. Lee A novel function of peroxiredoxin 1 (Prx-1) in apoptosis signal-regulating kinase 1 (ASK1)-mediated signaling pathway FEBS Lett 582 2008 1913 1918
25. D. Reczek, M. Berryman, and A. Bretscher Identification of EBP50: a PDZ-containing phosphoprotein that associates with members of the ezrin-radixin-moesin family J Cell Biol 139 1997 169 179 (Pubitemid 27444089)
26. + exchanger regulatory factor potentiates receptor activity Mol Cell Biol 20 2000 8352 8363
27. R.A. Cardone, A. Bellizzi, and G. Busco The NHERF1 PDZ2 domain regulates PKA-RhoA-p38-mediated NHE1 activation and invasion in breast tumor cells Mol Biol Cell 18 2007 1768 1780 (Pubitemid 46717558)
28. T. Shibata, M. Chuma, A. Kokubu, M. Sakamoto, and S. Hirohashi EBP50, a beta-catenin-associating protein, enhances Wnt signaling and is over-expressed in hepatocellular carcinoma Hepatology 38 2003 178 186 (Pubitemid 36775809)
29. + exchanger regulatory factor stabilizes epidermal growth factor receptors at the cell surface Mol Biol Cell 15 2004 5470 5480 (Pubitemid 39564739)
30. E.L. Kreimann, F.C. Morales, and J. de Orbeta-Cruz Cortical stabilization of beta-catenin contributes to NHERF1/EBP50 tumor suppressor function Oncogene 26 2007 5290 5299 (Pubitemid 47237631)
31. + exchanger regulatory factor 1 inhibits platelet-derived growth factor signaling in breast cancer cells Breast Cancer Res 10 2008 R5
32. M.M. Georgescu NHERF1: molecular brake on the PI3K pathway in breast cancer Breast Cancer Res 10 2008 106
33. A.O. Stemmer-Rachamimov, T. Wiederhold, and G.P. Nielsen NHE-RF, a Merlin-interacting protein, is primarily expressed in luminal epithelia, proliferative endometrium, and estrogen receptor-positive breast carcinomas Am J Pathol 158 2001 57 62 (Pubitemid 32096471)
34. T. Uttaravichien, V. Bhudhisawasdi, C. Pairojkul, and A. Pugkhem Intrahepatic cholangiocarcinoma in Thailand J Hepato-Biliary-Pancreatic Surg 6 1999 128 135
35. H. Nathan, T.M. Pawlik, C.L. Wolfgang, M.A. Choti, J.L. Cameron, and R.D. Schulick Trends in survival after surgery for cholangiocarcinoma: a 30-year population-based SEER database analysis J Gastrointest Surg 11 2007 1488 1496